相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation
Yangmei Deng et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Interaction Between P450 Eicosanoids and Nitric Oxide in the Control of Arterial Tone in Mice
Hantz C. Hercule et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
John D. Imig et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE
Kazuyoshi Inoue et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension
Marlina Manhiani et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Increased blood pressure in mice lacking cytochrome P450 2J5
Krairerk Athirakul et al.
FASEB JOURNAL (2008)
The V433M variant of the CYP4F2 is associated with ischemic stroke in male swedes beyond its effect on blood pressure
Cristiano Fava et al.
HYPERTENSION (2008)
Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease
Pietro Minuz et al.
HYPERTENSION (2008)
Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk
Katherine N. Theken et al.
PHARMACOGENOMICS (2007)
Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension
Harpreet Singh et al.
HYPERTENSION (2007)
Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues
Tracy C. DeLozier et al.
DRUG METABOLISM AND DISPOSITION (2007)
Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors
William B. Campbell et al.
HYPERTENSION (2007)
Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1)
Craig R. Lee et al.
PHARMACOGENETICS AND GENOMICS (2007)
Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension
J. H. Capdevila et al.
KIDNEY INTERNATIONAL (2007)
Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function
John M. Seubert et al.
CIRCULATION RESEARCH (2006)
Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel
Kiyoshi Nakagawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus
JS Wang et al.
CIRCULATION RESEARCH (2006)
Tumor necrosis factor α blockade increases renal cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension
AA Elmarakby et al.
HYPERTENSION (2006)
Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BKCa channels:: implications for soluble epoxide hydrolase inhibition
BT Larsen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension
JD Imig et al.
HYPERTENSION (2005)
Tie2 identifies a hematopoietic monocytes required for tumor lineage of proangiogenic vessel formation and a mesenchymal population of pericyte progenitors
M De Palma et al.
CANCER CELL (2005)
Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension
JV Gainer et al.
CIRCULATION (2005)
Regulation of mouse renal CYP2J5 expression by sex hormones
J Ma et al.
MOLECULAR PHARMACOLOGY (2004)
A peroxisome proliferator-activated receptor-α activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury
DN Muller et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice
A Hartner et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Heterogeneity of endothelial cells from different organ sites in T-cell subset recruitment
YC Lim et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Decreased renal cytochrome P4502C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension
XY Zhao et al.
HYPERTENSION (2003)
The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS
JW Newman et al.
JOURNAL OF LIPID RESEARCH (2002)
P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage
E Kaergel et al.
HYPERTENSION (2002)
Contribution of prostaglandin EP2 receptors to renal microvascular reactivity in mice
JD Imig et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
14,15-epoxyeicosa-5(Z)-enoic acid -: A selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries
KM Gauthier et al.
CIRCULATION RESEARCH (2002)
Cloning of CYP2J2 gene and identification of functional polymorphisms
LM King et al.
MOLECULAR PHARMACOLOGY (2002)
Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension
JD Imig et al.
HYPERTENSION (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Epoxygenase pathways of arachidonic acid metabolism
DC Zeldin
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin
JD Imig et al.
JOURNAL OF VASCULAR RESEARCH (2001)
Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids
ZG Yu et al.
CIRCULATION RESEARCH (2000)
A new method for measurement of blood pressure, heart rate, and activity in the mouse by radiotelemetry
PA Mills et al.
JOURNAL OF APPLIED PHYSIOLOGY (2000)
分享论文
